Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs Sells 36,261 Shares

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now directly owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Viemed Healthcare Stock Performance

VMD opened at $9.15 on Thursday. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The stock has a market cap of $356.30 million, a P/E ratio of 33.89 and a beta of 1.43. The stock’s 50 day simple moving average is $8.31 and its 200 day simple moving average is $7.53. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The company had revenue of $58.00 million for the quarter.

Hedge Funds Weigh In On Viemed Healthcare

Institutional investors have recently added to or reduced their stakes in the business. BBR Partners LLC purchased a new position in shares of Viemed Healthcare in the 3rd quarter worth $110,000. Millrace Asset Group Inc. raised its holdings in Viemed Healthcare by 13.3% in the third quarter. Millrace Asset Group Inc. now owns 231,322 shares of the company’s stock valued at $1,696,000 after buying an additional 27,084 shares during the period. Thrivent Financial for Lutherans lifted its position in Viemed Healthcare by 0.6% during the third quarter. Thrivent Financial for Lutherans now owns 3,425,693 shares of the company’s stock valued at $25,110,000 after buying an additional 21,047 shares in the last quarter. Bard Associates Inc. lifted its position in Viemed Healthcare by 1.1% during the third quarter. Bard Associates Inc. now owns 345,052 shares of the company’s stock valued at $2,529,000 after buying an additional 3,762 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its position in shares of Viemed Healthcare by 5.6% in the third quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock worth $222,000 after acquiring an additional 1,601 shares in the last quarter. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Featured Articles

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.